FR2376868A1 - Derives d'acides biliaires marques, utilisables pour le diagnostic medical - Google Patents

Derives d'acides biliaires marques, utilisables pour le diagnostic medical

Info

Publication number
FR2376868A1
FR2376868A1 FR7800395A FR7800395A FR2376868A1 FR 2376868 A1 FR2376868 A1 FR 2376868A1 FR 7800395 A FR7800395 A FR 7800395A FR 7800395 A FR7800395 A FR 7800395A FR 2376868 A1 FR2376868 A1 FR 2376868A1
Authority
FR
France
Prior art keywords
medical diagnosis
trademark
acid derivatives
biliary acid
tellurium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7800395A
Other languages
English (en)
French (fr)
Other versions
FR2376868B1 (https=
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GE Healthcare Ltd
Original Assignee
Radiochemical Centre Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Radiochemical Centre Ltd filed Critical Radiochemical Centre Ltd
Publication of FR2376868A1 publication Critical patent/FR2376868A1/fr
Application granted granted Critical
Publication of FR2376868B1 publication Critical patent/FR2376868B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0493—Steroids, e.g. cholesterol, testosterone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C07J9/005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
FR7800395A 1977-01-07 1978-01-09 Derives d'acides biliaires marques, utilisables pour le diagnostic medical Granted FR2376868A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB628/77A GB1592791A (en) 1977-01-07 1977-01-07 Selenium- or tellurium-containing bile acids and derivatives thereof

Publications (2)

Publication Number Publication Date
FR2376868A1 true FR2376868A1 (fr) 1978-08-04
FR2376868B1 FR2376868B1 (https=) 1981-05-22

Family

ID=9707693

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7800395A Granted FR2376868A1 (fr) 1977-01-07 1978-01-09 Derives d'acides biliaires marques, utilisables pour le diagnostic medical

Country Status (5)

Country Link
US (2) US4172085A (https=)
JP (2) JPS5387346A (https=)
DE (2) DE2800780A1 (https=)
FR (1) FR2376868A1 (https=)
GB (1) GB1592791A (https=)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7801908A (nl) * 1978-02-21 1979-08-23 Philips Nv Selenomethionine-75se bevattende oplossing, voor- zien van een thiol als stabilisator.
GB2028333B (en) * 1978-07-03 1982-10-27 Radiochemical Centre Ltd Selenium and tellurium derivatives of bile acids
US4363793A (en) * 1979-08-30 1982-12-14 State University Of New York Diagnostic radiopharmaceuticals for localization in target tissues exhibiting a regional pH shift relative to surrounding tissues
US4848349A (en) * 1987-04-29 1989-07-18 Sherman Igor A Substance and method for measuring hepatic blood flow
US5079240A (en) * 1990-03-15 1992-01-07 The Regents Of The University Of California Synthetic conjugated bile acid and method of use thereof
US5571783A (en) * 1993-03-09 1996-11-05 Clintec Nutrition Company Composition and method for treating patients with hepatic disease
US5506147A (en) * 1993-04-15 1996-04-09 Kolhouse; J. Fred Non-invasive evaluation of maldigestion and malaborption
US5602236A (en) * 1994-04-08 1997-02-11 Mallinckrodt Medical, Inc. Metal-containing steroid mimics and ligands useful in the preparation thereof
DE69719095T2 (de) * 1997-10-09 2003-07-24 Ice S.R.L., Reggio Emilia Gallensauersälze mit physiologisch aktiven metalle und ihre verwendung zur therapeutischen behandlung
US20050183190A1 (en) * 2002-03-15 2005-08-25 Hussey Patrick P. Goggle contoured for helmet engagement
US20050193478A1 (en) * 2003-10-27 2005-09-08 Hussey Patrick P. Goggle attachment system
EP2724345B1 (en) 2011-06-23 2018-10-31 Source Production & Equipment Co., Inc. A method of manufacturing a gamma radiation source
WO2016073767A1 (en) 2014-11-06 2016-05-12 Enanta Pharmaceuticals, Inc. Bile acid analogs an fxr/tgr5 agonists and methods of use thereof
JP2017535570A (ja) 2014-11-26 2017-11-30 エナンタ ファーマシューティカルズ インコーポレイテッド Ｆｘｒ／ｔｇｒ５アゴニストとしての胆汁酸類似体およびその使用方法
US11578097B2 (en) 2014-11-26 2023-02-14 Enanta Pharmaceuticals, Inc. Tetrazole derivatives of bile acids as FXR/TGR5 agonists and methods of use thereof
US10208081B2 (en) 2014-11-26 2019-02-19 Enanta Pharmaceuticals, Inc. Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
MX2017010376A (es) 2015-02-11 2017-12-20 Enanta Pharm Inc Análogos de ácido biliar como agonistas de fxr/tgr5 y métodos para el uso de los mismos.
CA2981503C (en) 2015-03-31 2023-09-19 Enanta Pharmaceuticals, Inc. Bile acid derivatives as fxr/tgr5 agonists and methods of use thereof
US10323060B2 (en) 2016-02-23 2019-06-18 Enanta Pharmaceuticals, Inc. Benzoic acid derivatives of bile acid as FXR/TGR5 agonists and methods of use thereof
WO2017147159A1 (en) * 2016-02-23 2017-08-31 Enanta Pharmaceuticals, Inc. Deuterated bile acid derivatives as fxr/tgr5 agonists and methods of use thereof
WO2017147174A1 (en) 2016-02-23 2017-08-31 Enanta Pharmaceuticals, Inc. Heteroaryl containing bile acid analogs as fxr/tgr5 agonists and methods of use thereof
CA3045023A1 (en) 2016-11-29 2018-06-07 Enanta Pharmaceuticals, Inc. Process for preparation of sulfonylurea bile acid derivatives
US10472386B2 (en) 2017-02-14 2019-11-12 Enanta Pharmaceuticals, Inc. Bile acid derivatives as FXR agonists and methods of use thereof
CA3058754A1 (en) 2017-04-07 2018-10-11 Enanta Pharmaceuticals, Inc. Process for preparation of sulfonyl carbamate bile acid derivatives
CN115260272A (zh) * 2022-08-17 2022-11-01 南宁师范大学 胆固醇硒氰酸酯类化合物及其制备方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2260997A1 (https=) * 1974-02-20 1975-09-12 Radiochemical Centre Ltd
FR2292465A1 (fr) * 1974-11-28 1976-06-25 Philips Duphar Derives selenyles et telluryles de steroides
NL7607274A (nl) * 1975-07-02 1977-01-04 Radiochemical Centre Ltd Radioactieve steroiden.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3784576A (en) * 1970-09-24 1974-01-08 Univ Michigan Halogenated cholesterol
DK290774A (https=) * 1973-06-08 1975-02-03 Schering Ag
NL7315287A (nl) * 1973-11-08 1975-05-12 Philips Nv Methode voor de bepaling van vetresorptie als- mede hierbij toegepaste stoffen en daarvan af- geleide preparaten.
GB2028333B (en) * 1978-07-03 1982-10-27 Radiochemical Centre Ltd Selenium and tellurium derivatives of bile acids

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2260997A1 (https=) * 1974-02-20 1975-09-12 Radiochemical Centre Ltd
FR2292465A1 (fr) * 1974-11-28 1976-06-25 Philips Duphar Derives selenyles et telluryles de steroides
NL7607274A (nl) * 1975-07-02 1977-01-04 Radiochemical Centre Ltd Radioactieve steroiden.

Also Published As

Publication number Publication date
US4172085A (en) 1979-10-23
JPS5387346A (en) 1978-08-01
US4202876A (en) 1980-05-13
FR2376868B1 (https=) 1981-05-22
DE2800781C2 (de) 1983-06-30
JPS587612B2 (ja) 1983-02-10
JPS5388331A (en) 1978-08-03
DE2800781A1 (de) 1978-07-13
GB1592791A (en) 1981-07-08
DE2800780A1 (de) 1978-07-13

Similar Documents

Publication Publication Date Title
FR2376868A1 (fr) Derives d'acides biliaires marques, utilisables pour le diagnostic medical
Majd et al. Hepatobiliary scintigraphy with 99mTc-PIPIDA in the evaluation of neonatal jaundice
Van der Sijp et al. Radioisotope determination of regional colonic transit in severe constipation: comparison with radio opaque markers.
Brunner et al. Gastrointestinal transit and 5‐ASA release from a new mesalazine extended‐release formulation
Mojaverian et al. Gastrointestinal transit of a solid indigestible capsule as measured by radiotelemetry and dual gamma scintigraphy
Traub et al. Phenylbutazone toxicosis in the foal
LaFrance et al. Decreased accumulation of isopropyl-iodoamphetamine (I-123) in brain tumors
Spivak et al. Diagnostic utility of hepatobiliary scintigraphy with 99mTc-DISIDA in neonatal cholestasis
MY133974A (en) Stable reagents for the preparation of radiopharmaceutiocals
Berquist et al. Diagnosis of Barrett’s esophagus by pertechnetate scintigraphy
ES2149733T1 (es) Composicion farmaceutica oral con liberacion modificada que contiene 5-asa y metodo para el tratamiento de enfermedades intestinales.
Wilding et al. Relationship between systemic drug absorption and gastrointestinal transit after the simultaneous oral administration of carbamazepine as a controlled‐release system and as a suspension of 15N‐labelled drug to healthy volunteers.
Nasmyth et al. Changes in the absorption of bile acids after total colectomy in patients with an ileostomy or pouch-anal anastomosis
Arnold et al. Etodolac, aspirin, and gastrointestinal microbleeding
ES2882848T3 (es) Método de obtención de imágenes de artritis
Moore et al. Effect of synthetic prostaglandin E1 analog on gastric emptying of meals in man
Cameron et al. Oral prednisolone metasulphobenzoate in the treatment of active ulcerative colitis
Rivera-Calimlim Impaired absorption of chlorpromazine in rats given trihexyphenidyl
Roy et al. Acute periostitis in early acquired syphilis
Jabbari et al. Role of acid secretion in aspirin-induced gastric mucosal injury
Cohen et al. Avoiding False‐Positive Joint Scans by the Use of Labeled Albumins
Carr Jr et al. Studies of uptake of the bretylium analogue, iodobenzyltrimethylammonium iodide, by non‐primate, monkey and human hearts.
Best et al. Time Pattern of Vitamin B12Co60 Urinary Excretion in Man After Oral Administration and Parenteral" Flushing"
Bauer et al. SCINTIGRAMS OF THE THYROID GLAND—The Diagnosis of Morphologic Abnormalities with I131
Czerniak et al. Usefulness of radionuclides in evaluation of stomach disorders

Legal Events

Date Code Title Description
ST Notification of lapse